Afimoxifene (Compound)

Synonyms:4-Hydroxytamoxifen, (Z)-4-Hydroxytamoxifen, Afimoxifene, 68047-06-3, Hydroxytamoxifen, trans-4-Hydroxytamoxifen, 4-Monohydroxytamoxifen, Tamogel, (Z)-4-(1-(4-(2-(Dimethylamino)ethoxy)phenyl)-2-phenylbut-1-en-1-yl)phenol, 68392-35-8, Ici 79280, 65213-48-1, (Z)-4-Hydroxy Tamoxifen, (E/Z)-4-Hydroxytamoxifen, (E/Z)-4-Hydroxy Tamoxifen, Z-4-hydroxytamoxifen, C26H29NO2, CHEMBL489, R-LIPOIC ACID POTASSIUM COMPUND, TAMOXIFEN, 4-HYDROXY-, (Z)-, MLS000069742, 1077-29-8, DTXSID7022384, CHEBI:44616, 95K54647BZ, 4-Hydroxy Tamoxifen, SMR000058939, 4-[(Z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol, 4-OH-TAM, [3H]4-OHT, 4-[(1Z)-1-[4-[2-(Dimethylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]phenol, 4-[(1Z)-1-{4-[2-(dimethylamino)ethoxy]phenyl}-2-phenylbut-1-en-1-yl]phenol, cis-4-Hydroxytamoxifen, SR-01000759243, Afimoxifene [USAN:INN], ICI 79,280, BRN 4910749, UNII-17197F0KYM, 4-(1-[4-(Dimethylaminoethoxy)phenyl]-2-phenyl-1-butenyl)phenol, CCRIS 8580, UNII-95K54647BZ, (Z)-4-OHT, 4-[(1z)-1-{4-[2-(dimethylamino)ethoxy]phenyl}-2-phenyl-1-buten-1-yl]phenol, 4-OH tamoxifen, (Z)-4-(1-(4-(2-(Dimethylamino)ethoxy)-phenyl)-2-phenylbut-1-en-1-yl)phenol, Tamogel (TN), 2bj4, Opera_ID_600, Afimoxifene (USAN/INN), 4-((1Z)-1-(4-(2-(dimethylamino)ethoxy)phenyl)-2-phenyl-1-butenyl)phenol, Phenol, 4-(1-(4-(2-(dimethylamino)ethoxy)phenyl)-2-phenyl-1-butenyl)-,, trans-4-(1-(4-(2-(Dimethylamino)ethoxy)phenyl)-2-phenyl-1-butenyl)phenol, SCHEMBL9189, BIDD:PXR0104, AFIMOXIFENE, Z-ISOMER, MLS001077346, BIDD:ER0193, cid_449459, DTXCID802384, BDBM20608, 17197F0KYM, GLXC-26379, HMS2231F20, EX-A4661, Tox21_200943, 4-[1-[4-[2-(Dimethylamino)ethoxy]phenyl]-2-phenyl-1-butenyl]phenol, HB2508, HB6040, HB6095, HSCI1_000353, HY-16950A, ICI-79280, MFCD00278780, MFCD00468090, s8956, (Z)-4-Hydroxytamoxifen (Z-4-OHT), 4-{1-[4-(2-Dimethylamino-ethoxy)-phenyl]-2-phenyl-but-1-enyl}-phenol, AKOS016010361, DB04468, Phenol, 4-((1Z)-1-(4-(2-(dimethylamino)ethoxy)phenyl)-2-phenyl-1-butenyl)-, Phenol, 4-(1-(4-(2-(dimethylamino)ethoxy)phenyl)-2-phenyl-1-butenyl)-, (Z)-, NCGC00164399-01, NCGC00164399-02, NCGC00258497-01, MS-26417, (Z)-4-Hydroxytamoxifen, >=98% Z isomer, CAS-68047-06-3, CS-0003592, C05011, D06551, A904472, 4-Hydroxytamoxifen (E) and (Z) isomers (50:50), Q4689254, SR-01000759243-3, SR-01000759243-5, BRD-K04210847-001-01-1, 4-Hydroxytamoxifen ≥70% Z isomer (remainder primarily E-isomer), (Z)-4-(1-(4-(2-(dimethylamino)ethoxy)phenyl)-2-phenylbut-1-enyl)phenol, 4-(1-(4-(2-(Dimethylamino)ethoxy)phenyl)-2-phenylbut-1-en-1-yl)phenol, 4-[(1Z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]-phenol, 4-{(1Z)-1-[4-(2-Dimethylamino-ethoxy)-phenyl]-2-phenyl-but-1-enyl}-phenol
Id:449459

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Afimoxifene's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Afimoxifene.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Afimoxifene.

Results found

Linked to

 

Label

Description

 

Substance

A Substance

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.